Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-09 Sale |
2024-02-12 4:03 pm |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $125.5 | $1,845,083 | 46,242 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 6:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
29,000 | $13.66 | $396,214 | 3,170,666 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 9:21 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
15,900 | $20.48 | $325,630 | 3,784,311 (Indirect Direct) |
View |
| 2021-11-17 Sale(A) |
2021-12-09 9:17 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
19,100 | $20.16 | $384,962 | 1,928,163 (Indirect Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 5:40 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
19,100 | $20.16 | $384,962 | 3,800,211 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-03 4:37 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
2,268 | $0 | 3,192,462 (Direct) |
View |
| 2025-01-27 Option Award |
2025-01-29 6:19 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
32,621 | $97.94 | 79,592 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 6:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,647 | $0 | 3,190,194 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-04 6:29 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,925 | $0 | 3,188,547 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,592 | $0 | 3,186,622 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:11 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
39,290 | $0 | 3,211,223 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:17 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
65,625 | $0 | 112,027 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,267 | $0 | 3,171,933 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-12 4:03 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $62.07 | 46,242 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-12 4:03 pm |
2018-05-05 2027-05-04 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $0 | 46,242 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:10 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
25,760 | $119.43 | 46,242 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,203 | $0 | 3,199,666 (Direct) |
View |
| 2023-04-21 Gift |
2023-10-04 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
627,705 | $0 | 3,198,463 (Indirect) |
View |
| 2023-10-02 Option Award |
2023-10-04 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,659 | $0 | 3,198,463 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-06 6:10 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,609 | $0 | 3,824,509 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:23 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
37,836 | $0 | 3,912,361 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 5:56 pm |
2024-05-02 2033-05-01 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
77,455 | $0 | 97,926 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 4:10 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,062 | $115.47 | 20,471 (Direct) |
View |
| 2023-05-01 Tax Withholding |
2023-05-03 4:10 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
524 | $115.47 | 20,471 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 4:10 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,062 | $0 | 20,471 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 6:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,724 | $0 | 3,810,457 (Direct) |
View |
| 2023-01-23 Option Award |
2023-01-25 4:59 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
3,275 | $109.88 | 19,933 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:29 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,573 | $0 | 3,808,733 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,092 | $0 | 3,807,160 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,409 | $0 | 5,122,068 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:18 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
54,435 | $0 | 5,184,727 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-05 5:11 pm |
2023-05-03 2032-05-02 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
75,728 | $0 | 92,186 (Direct) |
View |
| 2022-05-03 Tax Withholding |
2022-05-04 5:50 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
381 | $87.65 | 16,458 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-04 5:50 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
773 | $87.65 | 16,458 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-04 5:50 pm |
2020-05-03 2022-05-03 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
773 | $0 | 16,458 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:21 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,061 | $88.69 | 17,128 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 4:21 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
523 | $88.69 | 17,128 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 4:21 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,061 | $0 | 17,128 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:21 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,544 | $0 | 5,102,514 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 4:24 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
3,023 | $73.51 | 15,462 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
659 | $0 | 5,100,970 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
543 | $0 | 3,819,311 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
330 | $0 | 3,818,768 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-06 4:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
238 | $75.98 | 104,147 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-06 4:55 pm |
2019-05-04 2021-05-04 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
694 | $0 | 104,147 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-06 4:55 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
694 | $75.98 | 104,147 (Direct) |
View |
| 2021-05-04 Option Award |
2021-05-06 4:55 pm |
2022-05-04 2031-05-03 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
91,837 | $0 | 104,147 (Direct) |
View |
| 2021-05-01 Exercise |
2021-05-04 4:57 pm |
2021-05-01 2023-05-01 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,780 | $0 | 14,664 (Direct) |
View |
| 2021-05-01 Tax Withholding |
2021-05-04 4:57 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
611 | $74.5 | 14,664 (Direct) |
View |
| 2021-05-01 Exercise |
2021-05-04 4:57 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
1,780 | $74.5 | 14,664 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 8:06 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
166,322 | $0 | 9,611,044 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 8:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
3,818,438 | $0 | 9,611,044 (Indirect) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:28 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
41,667 | $0 | 3,846,216 (Direct) |
View |
Ownership |
2021-04-15 09:01 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
0 | $0 | 3,804,549 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 12:00 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
3,485 | $72.62 | 10,655 (Direct) |
View |